Navigation Links
Center for Clinical and Translational Science awards new pilot grants
Date:5/14/2013

The University of Illinois at Chicago's Center for Clinical and Translational Science has selected six research projects to receive pilot grants in 2013.

The $30,000 per year pilot grants, designed to give researchers a chance to test new ideas, have been given by the center since 2006.

"The pilot grants have been very successful at providing the opportunity for UIC investigators to develop their ideas and generate the preliminary data necessary for applying for those highly competitive grants from outside sources, like the National Institutes of Health," says Robin Mermelstein, co-director of the center and director of novel translational and collaborative studies.

"The grants also encourage collaboration among researchers from different departments and colleges who may not have a chance to work together otherwise," Mermelstein said.

The program has been highly competitive, receiving more than 200 applications over the past four years. Investigators across 10 colleges and more than 15 departments have received funding since its inception.

The 2013 pilot grant projects are:

Developing an alternative treatment for breast cancer

Debra Tonetti, associate professor in biopharmaceutical sciences, and Greg Thatcher, professor of medicinal chemistry, will investigate newly identified compounds that hold promise as alternatives to tamoxifen, the standard drug therapy for breast cancers fueled by estrogen (about 80 percent of all breast cancers) but which many cancers become resistant to. Tonetti's group has identified a possible alternative to tamoxifen, as well as a biomarker that indicates whether a tumor will respond to the new drug.

Preventing the spread of herpes virus

Herpes simplex virus type-1 (HSV-1), which causes cold sores, is one of the most common viruses that infects humans. The virus can cause blindness and encephalitis in rare cases. Once infected, a person carries the virus for life and can pass it on to others. Over the counter treatments can sometimes speed the healing of cold sores, but nothing can block the virus from entering a cell or spreading. Dr. Tibor Valyi-Nagy, associate professor of pathology, in collaboration with Deepak Shukla, associate professor of ophthalmology and visual science, will use their pilot grant to develop ways to block HSV-1 from entering cells or prevent life-long infection.

Iron absorption, obesity, and colorectal cancer

Obesity is a significant risk factor for developing colorectal cancer, the second leading cause of cancer-related death in the U.S., but how obesity and colorectal cancer are linked is poorly understood. Dr. Lisa Tussing-Humphreys, assistant professor of health promotion research in the department of medicine, and her group will investigate the connection between obesity and absorption of iron in the colon and how those factors may trigger colorectal cancer. They will design a clinical trial to examine the effects of dietary iron on the risk of developing colorectal cancer in obesity.

New targets for treating thrombo-inflammatory disease

Platelets and neutrophils are blood components that play a critical role in clotting and in the development of cardiovascular disease. Jaehyung Cho, assistant professor in pharmacology and anesthesiology, and colleagues have identified an enzyme that helps regulate blood factors. They will use their pilot grant to further investigate how the enzyme may influence the formation of dangerous, artery-blocking clots.

A new approach to treating hemophilia

People with hemophilia have defective or missing clotting factors, and for them, even the smallest cut can become a medical emergency. Standard therapy--replacing missing clotting factors--is expensive and can trigger an allergic response. Dr. Xin Huang, assistant professor in the Center for Molecular Biology of Oral Diseases and in periodontics in the College of Dentistry, and colleagues are investigating an alternative strategy that focuses on suppressing natural anticoagulation factors to develop a safer and more cost-effective therapy for treating hemophilia.

Measuring availability of unhealthy snacks and beverages in Chicago Public Schools

Jamie Chriqui, senior research scientist in the Institute for Health Research and Policy, and colleagues will collaborate with the Chicago Public Schools to collect data on the availability of junk foods, sugar-sweetened beverages and high-fat milks in vending machines and cafeteria lines. Their data will provide a "before" snapshot to compare with the new CPS Healthy Snack and Beverage Policy, set to launch in the fall.


'/>"/>

Contact: Sharon Parmet
sparmet@uic.edu
312-413-2695
University of Illinois at Chicago
Source:Eurekalert

Related biology news :

1. New Center for Carbon Measurement to drive UKs low carbon economy
2. Israel names Tel Aviv Universitys Renewable Energy Center a Center of Research Excellence
3. Heart study suggests city center pollution doubles risk of calcium build-up in arteries
4. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
5. UC Santa Cruz builds national data center for cancer genome research
6. UF to establish Faroe Island research center with help of baseball star
7. DOE Plasma Science Center Annual Meeting at Princeton Plasma Lab
8. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
9. Tufts Medical Center researchers finds marker in premies saliva predicts readiness to feed by mouth
10. University of Hawaii Cancer Center researchers create new anti-cancer drug
11. Center for North Sea oil expertise set to boost jobs and growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... (PRWEB) , ... December 02, ... ... (ETC), a consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing ... companies interested in supplying a vendor-supported, portable online UHPLC, with robust, probe-based ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... 30, 2016  GenomOncology today announced the appointment of ... Affairs.  Dr. Coleman will oversee clinical content ... knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with ... and clinical decision support, from quality control through reporting. ... , , ...
(Date:11/30/2016)... 2016 Biotest Pharmaceuticals Corporation (BPC), a leading ... the addition of its newest plasma collection center located ... . The 15,200 square foot state-of-the-art facility officially opened ... brings the total number of BPC,s plasma collection centers ... BPC,s Chief Executive Officer said "We are pleased to ...
Breaking Biology Technology: